Literature DB >> 17534698

cDNA microarray analysis of cyclosporin A (CsA)-treated human peripheral blood mononuclear cells reveal modulation of genes associated with apoptosis, cell-cycle regulation and DNA repair.

Ana Maria T Baião1, Pryscilla F Wowk, Paula Sandrin-Garcia, Cristina Moraes Junta, Ana Lúcia Fachin, Stephano S Mello, Elza T Sakamoto-Hojo, Eduardo A Donadi, Geraldo A S Passos.   

Abstract

Cyclosporin A (CsA) is a potent immunosuppressant that has been extensively used to attenuate patient immune response following organ transplantation. The molecular biological mechanism of CsA has been extensively investigated in human T cells, and it has been shown to involve modulation of the intracellular calcineurin pathway. However, it is plausible that this chemical immunosuppressant certainly up- or down-regulate many other biochemical pathways of immune cells. In the present study, we used the cDNA microarray method to characterize the gene expression profile of human peripheral blood mononuclear cells (PBMC) treated in vitro with CsA and controls. The CsA treated PBMC displayed statistically significant induction of genes involved in the control of cell-cycle regulation (TRRAP), apoptosis/DNA repair (PRKDC, MAEA, TIA1), DNA metabolism/response to DNA damage stimulus (PRKDC, FEN1), transcription (NR4A2, THRA) and cell proliferation (FEN1, BIN1), whose data have permitted identification of target genes involved in CsA immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534698     DOI: 10.1007/s11010-007-9505-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

Review 1.  The application of DNA microarrays in gene expression analysis.

Authors:  N L van Hal; O Vorst; A M van Houwelingen; E J Kok; A Peijnenburg; A Aharoni; A J van Tunen; J Keijer
Journal:  J Biotechnol       Date:  2000-03-31       Impact factor: 3.307

2.  Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.

Authors:  Penny G Ard; Chandrima Chatterjee; Sudeesha Kunjibettu; Leon R Adside; Lisa E Gralinski; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 3.  Design issues for cDNA microarray experiments.

Authors:  Yee Hwa Yang; Terry Speed
Journal:  Nat Rev Genet       Date:  2002-08       Impact factor: 53.242

Review 4.  Immunosuppressive therapy.

Authors:  B D Kahan
Journal:  Curr Opin Immunol       Date:  1992-10       Impact factor: 7.486

5.  DNA-dependent protein kinase: a potent inhibitor of transcription by RNA polymerase I.

Authors:  A Kuhn; T M Gottlieb; S P Jackson; I Grummt
Journal:  Genes Dev       Date:  1995-01-15       Impact factor: 11.361

6.  Trial of cyclosporin in corticosteroid-dependent chronic severe asthma.

Authors:  A G Alexander; N C Barnes; A B Kay
Journal:  Lancet       Date:  1992-02-08       Impact factor: 79.321

Review 7.  DNA double-strand break repair and V(D)J recombination: involvement of DNA-PK.

Authors:  S P Jackson; P A Jeggo
Journal:  Trends Biochem Sci       Date:  1995-10       Impact factor: 13.807

8.  Molecular identification and functional characterization of a novel protein that mediates the attachment of erythroblasts to macrophages.

Authors:  M Hanspal; Y Smockova; Q Uong
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

9.  Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine.

Authors:  J S Dummer; L T White; M Ho; B P Griffith; R L Hardesty; H T Bahnson
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

10.  Gene expression profiles in human cells submitted to genotoxic stress.

Authors:  Elza T Sakamoto-Hojo; Stephano S Mello; Elayne Pereira; Ana L Fachin; Renato S Cardoso; Cristina Moraes Junta; Paula Sandrin-Garcia; Eduardo A Donadi; Geraldo A S Passos
Journal:  Mutat Res       Date:  2003-11       Impact factor: 2.433

View more
  2 in total

1.  Selective clinical and immune response of the oligoclonal autoreactive T cells in Omenn patients after cyclosporin A treatment.

Authors:  A Lev; A J Simon; N Amariglio; G Rechavi; R Somech
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

2.  Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis.

Authors:  Weinong Han; Keyoumars Soltani; Mei Ming; Yu-Ying He
Journal:  Cancer Prev Res (Phila)       Date:  2012-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.